Based on our research and analysis, some interesting small cap COVID-19 Vaccine players that are traded on U.S. markets are ARCT, INO, ALT and VXRT. These four appear to have clinical trial data readouts and/or important start dates coming in Q4 2020. ALT and VXRT are starting Phase 1 Clinical Trials for their COVID-19 Vaccines in Q4 2020. ARCT has a readout of clinical trial data coming Q4 2020. INO will begin Phase 2/3 later this month. We eagerly await the data readouts.
Check out our Catalyst Cards for more information about each of these COVID-19 Vaccines, including links to the prior human clinical data for ARCT and INO:
Do you have a favorite of these four?